# Evaluation of 11 C-Choline PET-CT for Detection of Hepatocellular Carcinoma

Source: https://onco.cc/trials/nct01377220/  
OnCo record `nct01377220` (Trial). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)"; commercial use needs a licence.

## TL;DR

A phase 2 trial of Choline C-11 in Hepatocellular carcinoma, run by Commissariat A L'energie Atomique, with a status the registry has not verified recently.

## Summary

Evaluation of 11 C-Choline PET-CT for Detection of Hepatocellular Carcinoma is a phase 2 interventional study registered as NCT01377220 by Commissariat A L'energie Atomique, with 30 participants planned, started 2011-06 and due to reach its primary completion in 2013-06. Interventions recorded: 11C-Choline. Conditions recorded: Hepatocellular Carcinoma.

Linked to the drug Choline C-11 because the registry names it among its interventions and Hepatocellular carcinoma among its conditions. Registry record only: no result has been read by an editor.

## Fields

- Kind: Trial
- Last checked: 2026-09-22
- Tags: pipeline; ctgov-ingest
- Registry id: NCT01377220
- Phase: 2
- Setting: Evaluation of 11 C-Choline PET-CT for Detection of Hepatocellular Carcinoma
- Sponsor: Commissariat A L'energie Atomique
- Enrolled: 30

## Sources

- ClinicalTrials.gov NCT01377220: https://clinicaltrials.gov/study/NCT01377220

## Connected records

- cancers: [Hepatocellular carcinoma](https://onco.cc/cancers/hcc/)
- drugs: [Choline C-11](https://onco.cc/drugs/choline-c11/)

---
JSON: https://onco.cc/api/v1/entities/nct01377220.json